Printable version
Diplômé et docteur en médecine de l’Université de Lausanne, Pierre-Alain Raeber s’est rapidement spécialisé en médecine tropicale. En effet, en plus du titre de spécialiste FMH en médecine générale, il a aussi acquis en 1983 celui de spécialiste FMH en médecine tropicale.
Après avoir pratiqué la médecine tropicale au Bénin (Afrique de l’Ouest) et après avoir perfectionné ses connaissances en microbiologie et en médecine à Lausanne et à Paris Salpêtrière, P.-A. Raeber a rejoint l’Office fédéral de la santé publique (OFSP) d’abord comme adjoint scientifique (1985), puis comme chef de la section Maladies bactériennes et parasitaires (1993). En 1994 il devient chef a.i. de la division Épidémiologie et maladies infectieuses, poste qu’il occupera à plein titre de 1996 à mai 2008.
P.-A. Raeber a enseigné comme chargé de cours la microbiologie médicale à l’Université de Neuchâtel (1982-1996), puis comme privat docent (PD) une introduction à l’épidémiologie (1999-2007).
Expertise professionnelle de P.-A. Raeber
Médecine individuelle ambulatoire et hospitalière
Épidémiologie et méthodes de santé publique
Planification et (ré)organisation de projets
Gestion de crise
Direction stratégique, thématique, organisationnelle et personnelle
Supervision scientifique, rédaction de publications
Communication médiatique
29 October 2019
The Round Table Antibiotics is a Swiss non-profit interdisciplinary Association gathering experts from medicine, research and economics of almost all Swiss universities, as well as committed personalities from industry or elsewhere.
The aim of the Association Round Table Antibiotics is to drive Switzerland’s contribution to innovation, research, and development of measures against antimicrobial resistance, particularly by promoting the market introduction of new active substances, which should be available to all countries worldwide.
Additional information: www.roundtableantibiotics.ch
26 November 2017
On 9 November 2017, the Round Table on Antibiotics launched an appeal to the Federal Council to establish a dialogue in Switzerland between all partners involved in antibiotic research (academic research, economics, small and medium-sized enterprises, pharmaceutical industry, etc.). This dialogue should aim at defining, developing and implementing an innovative financing model for the research, development and marketing of new antibiotics that are financially accessible to all.
The text of the call of November 9, 2017 can be seen under "Publications"
8 November 2017
With the purpose of raising awareness of antibiotic resistance and improving the prudent use of antimicrobials, WHO (World Health Organisation) is organising a World Antibiotic Awareness Week since 2015. This year the event will be held from November 13 to 19. For the first time, Switzerland will actively participate to this week. Indeed, the crisis of bacterial resistance to antibiotics is such that an increasing number of infections is becoming difficult to treat, or even impossible. WHO is deeply concerned with this issue and is stimulating its state members to organise campaigns at the national level. Switzerland has already reacted to the antibiotic resistance issue by promoting a National Research Programme of 20 millions CHF(NRP 72) as well as a national Strategy on antibiotic resistance (StAR).
Via San Gottardo 92, 6900 Massagno, Switzerland - T : +41 91 960 05 55 - F : +41 91 960 05 56
